A citation-based method for searching scientific literature

Xichun Xiao, Yueli Gu, Genjie Wang, Shuxia Chen. Int J Biol Macromol 2019
Times Cited: 24







List of co-cited articles
122 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.
Maria T Di Martino, Emanuela Leone, Nicola Amodio, Umberto Foresta, Marta Lionetti, Maria R Pitari, Maria E Gallo Cantafio, Annamaria Gullà, Francesco Conforti, Eugenio Morelli,[...]. Clin Cancer Res 2012
174
20

Long noncoding-RNA component of mitochondrial RNA processing endoribonuclease is involved in the progression of cholangiocarcinoma by regulating microRNA-217.
Lingyu Tang, Yuting Wang, Huishan Wang, Boming Xu, Hao Ji, Guolong Xu, Xianxiu Ge, Quanpeng Li, Lin Miao. Cancer Sci 2019
15
26

LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma.
Xiangchou Yang, Haihao Ye, Muqing He, Xiaohai Zhou, Ni Sun, Wenjian Guo, Xiaoji Lin, He Huang, Ying Lin, Rongxin Yao,[...]. Biochem Biophys Res Commun 2018
38
16

LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer.
Yongfu Shao, Meng Ye, Qier Li, Weiliang Sun, Guoliang Ye, Xinjun Zhang, Yunben Yang, Bingxiu Xiao, Junming Guo. Oncotarget 2016
119
16

Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia.
Pia Hermanns, Alison A Bertuch, Terry K Bertin, Brian Dawson, Mark E Schmitt, Chad Shaw, Bernhard Zabel, Brendan Lee. Hum Mol Genet 2005
73
16

Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.
E Morelli, E Leone, M E Gallo Cantafio, M T Di Martino, N Amodio, L Biamonte, A Gullà, U Foresta, M R Pitari, C Botta,[...]. Leukemia 2015
75
16


Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia.
M Ridanpää, H van Eenennaam, K Pelin, R Chadwick, C Johnson, B Yuan, W vanVenrooij, G Pruijn, R Salmela, S Rockas,[...]. Cell 2001
297
12

An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA.
Yoshiko Maida, Mami Yasukawa, Miho Furuuchi, Timo Lassmann, Richard Possemato, Naoko Okamoto, Vivi Kasim, Yoshihide Hayashizaki, William C Hahn, Kenkichi Masutomi. Nature 2009
261
12

Unique features of long non-coding RNA biogenesis and function.
Jeffrey J Quinn, Howard Y Chang. Nat Rev Genet 2016
12

Recurrent and functional regulatory mutations in breast cancer.
Esther Rheinbay, Prasanna Parasuraman, Jonna Grimsby, Grace Tiao, Jesse M Engreitz, Jaegil Kim, Michael S Lawrence, Amaro Taylor-Weiner, Sergio Rodriguez-Cuevas, Mara Rosenberg,[...]. Nature 2017
148
12

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1.
N Amodio, M T Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, A M Gullà, M R Pitari, F Conforti, M Rossi,[...]. Cell Death Dis 2012
118
12

MiR-19b and miR-20a suppress apoptosis, promote proliferation and induce tumorigenicity of multiple myeloma cells by targeting PTEN.
Jie Yuan, Zhangyao Su, Wenchao Gu, Xianjuan Shen, Qiumin Zhao, Linying Shi, Chunjing Jin, Xudong Wang, Hui Cong, Shaoqing Ju. Cancer Biomark 2019
21
14

Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1.
Yi-Kun Zhang, Hua Wang, Yun Leng, Ze-Liang Li, Yue-Feng Yang, Feng-Jun Xiao, Qing-Fang Li, Xie-Qun Chen, Li-Sheng Wang. Biochem Biophys Res Commun 2011
81
12

Serum miR-29a as a marker of multiple myeloma.
Sabina Sevcikova, Lenka Kubiczkova, Lenka Sedlarikova, Ondrej Slaby, Roman Hajek. Leuk Lymphoma 2013
37
12

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Flavia Pichiorri, Sung-Suk Suh, Marco Ladetto, Michael Kuehl, Tiziana Palumbo, Daniela Drandi, Cristian Taccioli, Nicola Zanesi, Hansjuerg Alder, John P Hagan,[...]. Proc Natl Acad Sci U S A 2008
425
12

Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma.
Xianjuan Shen, Yan Ye, Jing Qi, Wei Shi, Xinhua Wu, Hongbing Ni, Hui Cong, Shaoqing Ju. Clin Chem Lab Med 2017
13
23

Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
Nidhi Gupta, Raman Kumar, Tulika Seth, Bhavuk Garg, Hem Chandra Sati, Alpana Sharma. J Cancer Res Clin Oncol 2019
17
17

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma.
Maria Teresa Di Martino, Virginia Campani, Gabriella Misso, Maria Eugenia Gallo Cantafio, Annamaria Gullà, Umberto Foresta, Pietro Hiram Guzzi, Maria Castellano, Anna Grimaldi, Vincenzo Gigantino,[...]. PLoS One 2014
81
12

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
S Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar, Jens Hillengass, Efstathios Kastritis, Paul Richardson,[...]. Lancet Oncol 2014
12


Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma.
Xiaoyan Qu, Min Zhao, Shuang Wu, Wenjun Yu, Jiaren Xu, Ji Xu, Jianyong Li, Lijuan Chen. Med Oncol 2014
40
12

Multiple myeloma.
Shaji K Kumar, Vincent Rajkumar, Robert A Kyle, Mark van Duin, Pieter Sonneveld, María-Victoria Mateos, Francesca Gay, Kenneth C Anderson. Nat Rev Dis Primers 2017
354
12


MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.
Aldo M Roccaro, Antonio Sacco, Brian Thompson, Xavier Leleu, Abdel Kareem Azab, Feda Azab, Judith Runnels, Xiaoying Jia, Hai T Ngo, Molly R Melhem,[...]. Blood 2009
236
12

Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.
Teru Hideshima, Constantine Mitsiades, Giovanni Tonon, Paul G Richardson, Kenneth C Anderson. Nat Rev Cancer 2007
628
12

MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
D-J Min, T Ezponda, M K Kim, C M Will, E Martinez-Garcia, R Popovic, V Basrur, K S Elenitoba-Johnson, J D Licht. Leukemia 2013
56
12

miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma.
Jian Xu, Yan Su, Aoshuang Xu, Fengjuan Fan, Shidai Mu, Lei Chen, Zhangbo Chu, Bo Zhang, Haifan Huang, Jiasi Zhang,[...]. Mol Ther 2019
21
14

MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib.
S Jagannathan, N Vad, S Vallabhapurapu, S Vallabhapurapu, K C Anderson, J J Driscoll. Leukemia 2015
49
12

Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Lenka Kubiczkova, Fedor Kryukov, Ondrej Slaby, Elena Dementyeva, Jiri Jarkovsky, Jana Nekvindova, Lenka Radova, Henrieta Greslikova, Petr Kuglik, Eva Vetesnikova,[...]. Haematologica 2014
72
12

A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression.
Nobuhiro Okada, Chao-Po Lin, Marcelo C Ribeiro, Anne Biton, Gregory Lai, Xingyue He, Pengcheng Bu, Hannes Vogel, David M Jablons, Andreas C Keller,[...]. Genes Dev 2014
181
8

lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition.
Nian Jiang, Xuedi Wang, Xianbiao Xie, Yan Liao, Ni Liu, Junfeng Liu, Nabo Miao, Jingnan Shen, Tingsheng Peng. Cancer Lett 2017
136
8

MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells.
Gero Doose, Andrea Haake, Stephan H Bernhart, Cristina López, Sujitha Duggimpudi, Franziska Wojciech, Anke K Bergmann, Arndt Borkhardt, Birgit Burkhardt, Alexander Claviez,[...]. Proc Natl Acad Sci U S A 2015
63
8

LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.
Xinxin Si, Ruochen Zang, Erbao Zhang, Yue Liu, Xiao Shi, Ershao Zhang, Lipei Shao, Andi Li, Nan Yang, Xiao Han,[...]. Oncotarget 2016
86
8

A long noncoding RNA connects c-Myc to tumor metabolism.
Chiu-Lien Hung, Ling-Yu Wang, Yen-Ling Yu, Hong-Wu Chen, Shiv Srivastava, Gyorgy Petrovics, Hsing-Jien Kung. Proc Natl Acad Sci U S A 2014
189
8

The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells.
Chengwu Zeng, Sichu Liu, Shuai Lu, Xibao Yu, Jing Lai, Yifan Wu, Shaohua Chen, Liang Wang, Zhi Yu, Gengxin Luo,[...]. Mol Cancer 2018
56
8

lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
Zehua Wang, Bo Yang, Min Zhang, Weiwei Guo, Zhiyuan Wu, Yue Wang, Lin Jia, Song Li, Wen Xie, Da Yang. Cancer Cell 2018
226
8

Somatic mutations of the KEAP1 gene in common solid cancers.
Nam Jin Yoo, Hyung Ran Kim, Yoo Ri Kim, Chang Hyeok An, Sug Hyung Lee. Histopathology 2012
163
8

Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Tomohiro Umezu, Hiroko Tadokoro, Kenko Azuma, Seiichiro Yoshizawa, Kazuma Ohyashiki, Junko H Ohyashiki. Blood 2014
331
8

Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis.
Bingzong Li, Hongxia Xu, Huiying Han, Sha Song, Xiaojuan Zhang, Lu Ouyang, Chen'ao Qian, Yating Hong, Yingchun Qiu, Wenqi Zhou,[...]. Oncogene 2018
50
8

Ibrutinib targets microRNA-21 in multiple myeloma cells by inhibiting NF-κB and STAT3.
Jing Ma, Wei Gong, Su Liu, Qian Li, Mengzheng Guo, Jinhan Wang, Suying Wang, Naiyao Chen, Yafei Wang, Qiang Liu,[...]. Tumour Biol 2018
8
25

Circulating microRNAs in hematological diseases: principles, challenges, and perspectives.
Sarah Grasedieck, Antonio Sorrentino, Christian Langer, Christian Buske, Hartmut Döhner, Daniel Mertens, Florian Kuchenbauer. Blood 2013
97
8

miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1.
Hongyan Wang, Qiang Ding, Mingjun Wang, Mingwei Guo, Qi Zhao. Hematology 2019
11
18

Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma.
Nicola Amodio, Maria Eugenia Gallo Cantafio, Cirino Botta, Valter Agosti, Cinzia Federico, Daniele Caracciolo, Domenica Ronchetti, Marco Rossi, Christoph Driessen, Antonino Neri,[...]. Cancers (Basel) 2019
18
11

Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma.
Michael A Tessel, Ashley L Benham, Nancy L Krett, Steven T Rosen, Preethi H Gunaratne. Horm Cancer 2011
42
8

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma.
Maria Angelica Stamato, Giada Juli, Enrica Romeo, Domenica Ronchetti, Mariamena Arbitrio, Daniele Caracciolo, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone, Nicola Amodio. Oncotarget 2017
41
8

miR-22 suppresses DNA ligase III addiction in multiple myeloma.
Daniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, Eugenio Morelli, Martina Montesano, Cirino Botta, Francesca Scionti, Daniela Talarico, Emanuela Altomare, Maria Eugenia Gallo Cantafio,[...]. Leukemia 2019
26
8


Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells.
Ze Tian, Jian-jun Zhao, Yu-Tzu Tai, Samir B Amin, Yiguo Hu, Allison J Berger, Paul Richardson, Dharminder Chauhan, Kenneth C Anderson. Blood 2012
57
8

Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.
Mu Hao, Meirong Zang, Lei Zhao, Shuhui Deng, Yan Xu, Fang Qi, Gang An, Yu Qin, Weiwei Sui, Fei Li,[...]. Oncotarget 2016
30
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.